Paper Details
- Home
- Paper Details
Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia.
Author: ElisafM, KeiA, LiberopoulosE N, MikhailidisD P
Original Abstract of the Article :
BACKGROUND: Use of a statin at a standard dose may be insufficient for the treatment of mixed dyslipidaemia. Whether switch to the highest dose of rosuvastatin (40 mg) or add-on nicotinic acid (NA) or fenofibrate is more efficacious remains unknown. PATIENTS AND METHODS: This was a prospective, ran...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1111/ijcp.12098
データ提供：米国国立医学図書館（NLM）
Comparison of Switch to the Highest Dose of Rosuvastatin vs. Add-on Nicotinic Acid vs. Add-on Fenofibrate for Mixed Dyslipidaemia
This research investigates the effectiveness of different strategies for managing mixed dyslipidemia, a condition characterized by abnormal levels of various lipids in the blood. It's like navigating a complex desert landscape, where each path represents a different treatment approach for managing dyslipidemia.
Effective Strategies for Managing Mixed Dyslipidemia
The study found that switching to the highest dose of rosuvastatin and adding nicotinic acid were more effective in reducing non-HDL cholesterol levels compared to adding fenofibrate. This suggests that these strategies could be more beneficial for patients with mixed dyslipidemia who have not achieved their lipid targets with standard statin therapy. It's like choosing the most efficient path across the desert – the research suggests that these treatment strategies could lead to more favorable outcomes for patients.
Managing Lipid Levels for Better Health
This research highlights the importance of managing lipid levels for overall health. It's like ensuring the proper flow of water through a desert oasis – maintaining healthy lipid levels is essential for preventing cardiovascular disease and other health problems. This research provides valuable insights into effective strategies for managing mixed dyslipidemia and improving patient outcomes.
Dr.Camel's Conclusion
This research highlights the effectiveness of switching to the highest dose of rosuvastatin and adding nicotinic acid in managing mixed dyslipidemia. It's like choosing the best path through a complex desert landscape – these strategies could lead to more favorable outcomes for patients. This research emphasizes the importance of individualized treatment plans and the continuous evaluation of lipid levels to achieve optimal health outcomes.
Date :
- Date Completed 2013-11-19
- Date Revised 2015-11-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.